57th ASH Annual Meeting and Exposition (December 5-8, 2015): 902. Health Services and Outcomes Research – Malignant Diseases: Toxicities of Therapy

Health Services and Outcomes Research – Malignant Diseases Oral and Poster Abstracts
Oral

Chapin Theater (W320), Level 3 (Orange County Convention Center)

Moderators:

Thomas W. LeBlanc, MD, MA, Duke University School of Medicine and Alix Eden Seif, MD, MPH, Children's Hospital of Philadelphia

Disclosures:

LeBlanc: Epi-Q: Consultancy ; Helsinn Therapeutics: Honoraria , Research Funding ; Boehringer Ingelheim: Membership on an entity’s Board of Directors or advisory committees ; Flatiron: Consultancy .

4:30 PM

877

Cognitive, Behavior and Academic Problems in Adolescent Survivors of Childhood Acute Lymphoblastic Leukemia (ALL): A Report from the Childhood Cancer Survivor Study

Lisa M Jacola, PhD¹^*, Kim Edelstein, PhD, CPsych²^*, Wei Liu, PhD³^*, Ching-Hon Pui, MD⁴, Robert J. Hayashi, MD⁵^*, Nina Kadan-Lottick, MD, MSPH⁶^*, Deokumar Srivastava, PhD³^*, Tara O Henderson, MD, MPH⁷, Leslie L. Robison, PhD, MPH⁸, Gregory T. Armstrong, MD, MSCE⁸^* and Kevin R. Krull, PhD⁹^*

¹Psychology, St. Jude Children's Research Hospital, Memphis, TN
²Pencer Brain Tumor Centre, Princess Margaret Cancer Center, Toronto, ON, Canada
³Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
⁴Oncology, St. Jude Children's Research Hospital, Memphis, TN
⁵Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, MO
⁶Pediatrics, Yale Univ. School of Medicine, New Haven, CT
⁷Comer Children's Hospital, University of Chicago, Chicago, IL
⁸Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN
⁹Psychology, Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN

4:45 PM

878

Increased Fracture Risk in Patients with Untreated Chronic Lymphocytic Leukemia (CLL): A Population-Based Analysis

Adam J Olszewski, MD¹, Roee Gutman, Ph.D.²^* and Charles B Eaton, MD, MS³^*

¹Division of Hematology-Oncology, Alpert Medical School of Brown University, Providence, RI
²Department of Biostatistics, Brown University, Providence, RI
³Department of Epidemiology, School of Public Health of Brown University, Providence, RI

5:00 PM

879

Statin Therapy Improves Multiple Myeloma (MM) Specific Surviva

Kristen M. Sanfilippo, MD, MPHS^1,2, Jesse Keller, MD³, Suhong Luo, MPH⁴^*, Brian F. Gage, MD, MSc⁵^*, Gerald Moskowitz⁶^* and Kenneth R Carson, MD, PhD^7,8

¹Division of Hematology, Washington University School of Medicine, Saint Louis, MO
²Research Service, St Louis Veterans Administration Medical Center, St Louis, MO
³Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
⁴Research Service, St Louis Veterans Administration Medical Center, St. Louis, MO
⁵Department of Medicine, Washington University Medical School, Saint Louis, MO
⁶Department of Medicine, Division of General Medical Sciences, Washington University St. Louis School of Medicine, Saint Louis
⁷Washington University School of Medicine, Saint Louis, MO
⁸Medicine, St Louis Veterans Administration Medical Center, St Louis, MO

5:15 PM

880

Cardiovascular Disease in Adolescents and Young Adults with Hematologic Malignancies

Chun Chao, PhD¹, Lanfang Xu, MS²^*, Cooper Robert, MD³^*, Smita Bhatia, MD, MPH⁴^* and Saro Armenian, DO, MPH⁵

¹Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA
²Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA
³Department of Pediatrics, Kaiser Permanente Southern California, Pasadena, CA
⁴Institute of Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁵Department of Population Sciences, City of Hope, Duarte, CA

5:30 PM

881

Toxicity of Maintenance Rituximab in Older Adults with Non-Hodgkin Lymphoma

Matthew J. Matasar, MD, MS¹, Coral L. Atoria, MS²^*, Elena B. Elkin, PhD²^* and Chadi Nabhan, MD³

¹Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL

5:45 PM

882

The Evolution of Management and Survival Outcomes of Waldenström Macroglobulinemia (WM) in the United States (US)

Adam J. Olszewski, MD^1,2, Jaleh Fallah, MD², Charles B Eaton, MD, MS³^*, Steven P Treon, MD, PhD⁴ and Jorge J Castillo, MD⁴

¹Division of Hematology-Oncology, Alpert Medical School of Brown University, Providence, RI
²Department of Medicine, Memorial Hospital of Rhode Island, Pawtucket, RI
³Department of Epidemiology, School of Public Health of Brown University, Providence, RI
⁴Bing Center for WM, Dana Farber Cancer Institute, Boston, MA

See more of: Health Services and Outcomes Research – Malignant Diseases
See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

902.O3.6 902. Health Services and Outcomes Research – Malignant Diseases: Toxicities of Therapy